Studies for Package Information Leaflets Readability Testing
readability tested PILs can be used to support other PILs creating
readability testing exemptions. PILs with similar indications,
therapeutic areas, active ingredients or combination medicines can
be used for bridging.
Pharma-EU’s three years of readability testing experience
qualifies us to write expert bridging studies and assessments. We have
over 100 bridging studies to date with a 100% success rate.
Bridging Study Reports
- Identify PILs which qualify for exemption
- Reformat PILs to QRD allowing
for bridging study exemptions
- Prepare the bridging studies complete
with the CV of the person responsible for preparing the report
the PILs and bridging studies through the procedure as needed
Testing Providers for: